Drug Approval | October 14, 2025
Biocon gets 1 USFDA observation for Cranbury site
The Cranbury facility represents a strategic advancement of the company's operations in the Unted States
The Cranbury facility represents a strategic advancement of the company's operations in the Unted States
New offering to debut at the 32nd ESGCT Congress, October 7–10, 2025, in Seville, Spain
States exhorted to ensure rational use of cough syrups, particularly among children, as most coughs are self-limiting and do not require pharmacological treatment
With global certification in place, the Ambernath site expands Supriya’s footprint beyond APIs into high-margin formulations
_LOGO_256_384.jpg){kind=logo}
The association called for an end to the constant issuance of regulatory circulars that make operations unpredictable and capital-intensive.
The facility has been classified as Voluntary Action Indicated
ProBioGen will oversee the design, construction, and operation of the 4,600-square-meter GMP manufacturing unit
The Ma’anshan site approval covers pastilles, oral liquids, and powders
Sun Pharma's Halol plant gets OAI classification from US FDA inspection
Delegates also visited Emami’s WHO-GMP-certified manufacturing plant and Zandu Foundation for Healthcare farms for hands-on exposure to quality practices,
Subscribe To Our Newsletter & Stay Updated
